We are live on ! Find out more
NA

Neuburgh Advisers Portfolio holdings

AUM $3.22B
1-Year Est. Return 3.74%
This Fund
S&P 500
This Quarter Est. Return
+14.2%
1 Year Est. Return
+3.74%
3 Year Est. Return
+55.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.94B
AUM Growth
+$391M
Cap. Flow
+$53.6M
Cap. Flow %
1.82%
Top 10 Hldgs %
25.81%
Holding
934
New
40
Increased
363
Reduced
159
Closed
24

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$10.5M
2
MRK icon
Merck
MRK
+$10.2M
3
HD icon
Home Depot
HD
+$7.4M
4
IP icon
International Paper
IP
+$7.22M
5
ETN icon
Eaton
ETN
+$5.86M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$13.6M
2
CI icon
Cigna
CI
+$8.46M
3
VLO icon
Valero Energy
VLO
+$8.29M
4
BBY icon
Best Buy
BBY
+$8.19M
5
DXC icon
DXC Technology
DXC
+$6.89M

Sector Composition

Rank Sector Weight
1 Healthcare 19.11%
2 Technology 15.54%
3 Financials 14.48%
4 Consumer Discretionary 11.85%
5 Industrials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYBR
876
DELISTED
CyberArk
CYBR
$25K ﹤0.01%
208
– –
ONC
877
BeOne Medicines Ltd
ONC
$32.8B
$25K ﹤0.01%
192
– –
DBX icon
878
Dropbox
DBX
$7.6B
$24K ﹤0.01%
1,122
+34
+3% +$792
FIVN icon
879
FIVE9
FIVN
$2.11B
$24K ﹤0.01%
462
+22
+5% +$1.12K
KALV
880
DELISTED
KalVista Pharmaceuticals
KALV
$24K ﹤0.01%
836
– –
CSOD
881
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$24K ﹤0.01%
442
+34
+8% +$1.88K
ELLI
882
DELISTED
Ellie Mae Inc
ELLI
$24K ﹤0.01%
242
+22
+10% +$1.91K
CBAY
883
DELISTED
Cymabay Therapeutics
CBAY
$23K ﹤0.01%
1,738
– –
ALEC icon
884
Alector
ALEC
$168M
$22K ﹤0.01%
+1,190
New +$22.5K
MYOK
885
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$22K ﹤0.01%
416
+96
+30% +$4.42K
APPF icon
886
AppFolio
APPF
$6.38B
$21K ﹤0.01%
264
+22
+9% +$1.47K
CAE icon
887
CAE Inc. Common Shares
CAE
$8.3B
$21K ﹤0.01%
944
– –
REPL icon
888
Replimune Group
REPL
$941M
$21K ﹤0.01%
1,394
– –
OPTU
889
Optimum Communications Inc
OPTU
$298M
$20K ﹤0.01%
944
+128
+16% +$2.59K
GDDY icon
890
GoDaddy
GDDY
$11B
$20K ﹤0.01%
264
– –
AYX
891
DELISTED
Alteryx Inc
AYX
$20K ﹤0.01%
240
+16
+7% +$1.16K
AQST icon
892
Aquestive Therapeutics
AQST
$464M
$16K ﹤0.01%
+2,332
New +$16.3K
COUP
893
DELISTED
Coupa Software Incorporated
COUP
$16K ﹤0.01%
176
– –
IOVA icon
894
Iovance Biotherapeutics
IOVA
$1.82B
$15K ﹤0.01%
1,598
-170
-10% -$1.65K
VRNT
895
DELISTED
Verint Systems
VRNT
$15K ﹤0.01%
503
+32
+7% +$814
CLDR
896
DELISTED
Cloudera, Inc.
CLDR
$15K ﹤0.01%
1,364
+66
+5% +$849
NUAN
897
DELISTED
Nuance Communications, Inc.
NUAN
$14K ﹤0.01%
961
+37
+4% +$513
ALTR
898
DELISTED
Altair Engineering Inc
ALTR
$12K ﹤0.01%
320
+16
+5% +$538
SNDX icon
899
Syndax Pharmaceuticals
SNDX
$1.69B
$11K ﹤0.01%
2,048
-400
-16% -$2.28K
TBPH icon
900
Theravance Biopharma
TBPH
$874M
$11K ﹤0.01%
484
– –
34 35
36
37 38

Similar funds

FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
EP
Elkfork Partners Portland, Oregon $4.11B AUM 5.26% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return

Neuburgh Advisers's Q1 2019 Portfolio in Review

As of Q1 2019, Neuburgh Advisers held 934 positions worth $2.94B, up 15% from $2.55B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Neuburgh Advisers's Q1 2019 filing shows 40 new, 363 increased, 159 reduced and 24 closed positions. Its largest new stake was Capri Holdings: 122,060 shares worth $5.58M. The largest sale was Marathon Petroleum, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

  • Neuburgh Advisers's largest Q1 2019 buy was Capri Holdings: 122,060 shares worth $5.58M.
  • Neuburgh Advisers added most to Chevron in Q1 2019, an estimated $10.5M increase.
  • Neuburgh Advisers's biggest Q1 2019 reduction was Marathon Petroleum, cutting an estimated $13.6M.
  • Neuburgh Advisers fully exited SunTrust Banks, Inc. in Q1 2019, selling an estimated $3.64M.
  • Neuburgh Advisers's ten largest holdings make up 26% of its $2.94B portfolio in Q1 2019.
  • Neuburgh Advisers opened 40 new positions and closed 24 in Q1 2019.
  • Neuburgh Advisers's portfolio value rose 15% quarter-over-quarter to $2.94B.

Based on Neuburgh Advisers's 13F filing for Q1 2019, filed 13 May 2019.